MARKET

BK-PRC

BNY MELLON
BK-PRC
NYSE
Delisted
P/E
P/S
P/B
MARKET CAP
5.55
1.343
0.4936
582,966,000.00
Sysco Raises $1.25 Billion Through Senior Notes Offering
Reuters · 19h ago
BNY clients hedge dollar exposure by most since 2023, bank says
Reuters · 1d ago
Teijin Pharma Applies for Japanese Approval of Weekly Pediatric Growth Hormone Treatment
Reuters · 2d ago
Ascendis Pharma reports FY 2025 net loss of EUR 228 million, narrowing 40%
Reuters · 2d ago
BlackRock MuniYield New York Quality Fund Inc. completes mergers with BNY and MHN
Reuters · 4d ago
Health Canada genehmigt Yorvipath von Ascendis Pharma für die Behandlung von chronischem Hypoparathyreoidismus
Reuters · 02/06 20:20
Health Canada Approves Yorvipath by Ascendis Pharma for Chronic Hypoparathyroidism
Reuters · 02/06 20:20
Cibus Partners with John Innes Centre for Precision Breeding Initiative
Reuters · 02/06 12:00
More

Webull offers BNY MELLON stock information, including NYSE: BK-PRC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BK-PRC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BK-PRC stock methods without spending real money on the virtual paper trading platform.